The European Medicines Agency’s Committee for Medicinal Products for Human Use previously issued a positive opinion ...

Mumbai: Global pharma major Lupin Limited has announced that the Committee for Medicinal Products for Human Use (CHMP) of the ...

Lupin said the Committee for Medicinal Products for Human Use (CHMP) has backed the approval of the biosimilar, to be ...

Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the EU approval of mNexspike ...

AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union (EU) for subcutaneous self-administration as a pre-filled pen for adult patients with systemic lupus erythematosus (SLE) on ...

UK pharma major AstraZeneca today revealed that Saphnelo (anifrolumab) has been approved in the European Union (EU) for ...

FDA approves AstraZeneca and Daiichi's Enhertu combo for first-line HER2-positive breast cancer, while the EU clears Saphnelo ...

Saphnelo has been approved in the European Union, EU, for subcutaneous self-administration as a pre-filled pen for adult ...

Biologics are manufactured from established cell cultures for disease treatment, but the FDA has specific expectations for ...

(Alliance News) - AstraZeneca PLC on Tuesday said its drug Saphnelo, or anifrolumab, has been approved in the European Union as a new pre-filled pen for systemic lupus erythematosus. The Cambridge, ...

Biosimilar developers achieve key European approvals for denosumab and golimumab, enhancing patient access while facing US ...